`

Evexta Bio

Biotechnology Research

Specialities :
Pharmaceuticals
Research & development
Oncology
Biotech
Kif20a inhibitor

+4

revenue-icon Revenue
11M - 100M
funding-icon Total Funding
--
size-icon Size
11 - 50

Frequently Asked Questions About Evexta Bio

What does Evexta bio do?+

Evexta Bio, formerly #Diaccurate, is a biopharmaceutical company exploring the new frontiers of #oncology in search of daring novel therapeutic approaches with the potential to save lives. Now in the clinic, the French biotech is currently developing two proprietary therapeutic assets with novel mechanisms of action across several indications: - Rupitasertib, formerly DIACC3010, an optimized S6K inhibitor with efficient AKT1/AKT3 control of feed-back loop. The oral anti-tumor agent is expected to enter phase 2/3 clinical trial in refractory ER+ HER2- metastatic breast cancer. - EVX020, formerly DIACC2020, an antibody-drug conjugate program using a sole-in-class KIF20A kinesin inhibitor as payload in...

What are Evexta bio's specialties? +

Pharmaceuticals,research & development,oncology,biotech,kif20a inhibitor,truffle capital,rupitasertib,s6k akt1/3 inhibitor,and diaccurate

What is Evexta bio's industry? +

Evexta bio operates in the Biotechnology research industry.

What is Evexta bio's revenue? +

Evexta bio's revenue is 11m - 100m

What is Evexta bio's company size? +

Evexta bio has 11 - 50 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.